David A. Siegel Baxter International Inc Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Baxter International Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 454,750 shares of BAX stock, worth $15.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

454,750

Previous 1,419,950 67.97%

Holding current value

$15.2 Million

Previous $54.9 Million 64.59%

% of portfolio

0.05%

Previous 0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $36.6 Million - $42.2 Million	-965,200 Reduced 67.97%	454,750 $19.4 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $21.5 Million - $26.4 Million	-678,300 Reduced 32.33%	1,419,950 $54.9 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $42.5 Million - $56.1 Million	-1,138,100 Reduced 35.17%	2,098,250 $79.2 Million
Q2 2023 Aug 14, 2023	SELL	$39.98 - $47.68 $109 Million - $129 Million	-2,715,500 Reduced 45.62%	3,236,350 $147 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $61.1 Million - $85.4 Million	1,625,300 Added 37.57%	5,951,850 $241 Million

Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $72.3 Million - $84 Million	1,455,700 Added 50.71%	4,326,550 $221 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $15.5 Million - $19.2 Million	287,000 Added 11.11%	2,870,850 $155 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $25.3 Million - $31.7 Million	395,900 Added 18.09%	2,583,850 $166 Million
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $59.5 Million - $69.2 Million	-773,600 Reduced 26.12%	2,187,950 $170 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $63.8 Million - $74.6 Million	-855,464 Reduced 22.41%	2,961,550 $254 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $94.8 Million - $107 Million	1,285,200 Added 50.76%	3,817,014 $307 Million
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $45.2 Million - $49.4 Million	-561,300 Reduced 18.15%	2,531,814 $204 Million
Q1 2021 May 17, 2021	BUY	$76.38 - $86.03 $649,230 - $731,255	8,500 Added 0.28%	3,093,114 $261 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $42.6 Million - $46.5 Million	564,800 Added 22.41%	3,084,614 $248 Million
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $600,399 - $695,445	7,665 Added 0.31%	2,519,814 $203 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $117 Million - $140 Million	1,492,100 Added 146.28%	2,512,149 $216 Million
Q1 2020 May 15, 2020	BUY	$71.57 - $93.3 $31.5 Million - $41.1 Million	440,719 Added 76.07%	1,020,049 $82.8 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $84.4 Million - $97.3 Million	-1,100,300 Reduced 65.51%	579,330 $48.4 Million
Q3 2019 Nov 14, 2019	BUY	$81.4 - $89.78 $35.2 Million - $38.9 Million	433,000 Added 34.73%	1,679,630 $147 Million
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $29.8 Million - $33.4 Million	405,667 Added 48.24%	1,246,630 $102 Million
Q1 2019 May 15, 2019	BUY	$64.48 - $81.31 $3.91 Million - $4.93 Million	60,597 Added 7.77%	840,963 $68.4 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $118 Million - $149 Million	-1,920,192 Reduced 71.1%	780,366 $51.4 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $33.7 Million - $37.1 Million	-477,100 Reduced 15.01%	2,700,558 $208 Million
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $7.2 Million - $8.56 Million	-113,500 Reduced 3.45%	3,177,658 $235 Million
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $25.3 Million - $29.3 Million	-404,800 Reduced 10.95%	3,291,158 $214 Million
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $14.5 Million - $15.6 Million	236,000 Added 6.82%	3,695,958 $239 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $206 Million - $224 Million	3,459,958	3,459,958 $217 Million

Others Institutions Holding BAX

# of Institutions

1,023

Shares Held

442M

Call Options Held

4.22M

Put Options Held

2.52M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account